CoChat

At the Interface of Tumor-Associated Macrophages and Fibroblasts: Immune-Suppressive Networks and Emerging Exploitable Targets

Timperi, Eleonora, Croizer, Hugo, Khantakova, Darya, Rana, Mhaidly, Molgora, Martina, Guerriero, Jennifer L., Mechta-Grigoriou, Fatima, Romano, Emanuela · 2024 · Clinical Cancer Research

The DOI matches its Crossref record; 119 of the 120 references it cites were found in a registry or an index.

Abstract

Tumor-associated macrophages (TAM) constitute a prominent immune cell population within various solid cancers, playing a pivotal role in disease progression. Their increased numbers and frequencies often strongly correlate with resistance to therapy and reduced overall survival rates. Within the complex ecosystem of the tumor microenvironment (TME), activated cancer-associated fibroblasts (CAF) are expanded and contribute significantly to tumor growth and metastasis and chemotherapy or immunotherapy resistance. CAFs exert a critical influence on TAM phenotypes and functions by orchestrating the reprogramming of tissue-infiltrating monocytes, thereby modulating their survival and differentiation. This reciprocal interaction between TAMs and CAFs forms a crucial axis in fostering a suppressive crosstalk within the TME, mediated by a diverse array of signals exchanged between these cell types. Recent advancements in single-cell RNA sequencing technologies and spatial transcriptomics have enhanced our comprehension of the signaling dynamics at the interface between TAMs and CAFs, including their spatial distribution within the tissue. In this review, we delve into the latest discoveries elucidating the biology of TAM and CAF crosstalk. We examine the complexity of TAM–CAF and CAF–TAM interactions within the TME of solid cancers, with particular focus on ligand–receptor interactions and clinically significant targets for novel therapeutic strategies.

Overview

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-24-1690

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 119 references

Research works printed but not linked: 1

  1. Nagano, 2021, CD204-positive macrophages accumulate in breast cancer tumors with high levels of infiltrating lymphocytes and programmed death ligand-1 expression, Oncol Lett, 21, 36

Cited by

See all 66

Metadata

Authors
Timperi, E., Croizer, H., Khantakova, D., Rana, M., Molgora, M., Guerriero, J. L., Mechta-Grigoriou, F., & Romano, E.
Affiliations
  • Fondazione Santa Lucia (IT)
  • Inserm (FR)
  • Washington University in St. Louis (US)
  • 2Institut Curie, Stress and Cancer Laboratory, Équipe Labélisée par la Ligue Nationale Contre le Cancer, PSL Research University, Paris, France.
  • Moffitt Cancer Center (US)
  • Brigham and Women's Hospital (US)
Corresponding author
Romano, Emanuela
Venue
Clinical Cancer Research
Published
2024-09-23
Volume
30
Issue
23
Pages
5242-5251
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W4402731724
Cited by
49
References
120
Citations by year
2026: 29 · 2025: 20
FWCI
2.16
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
tumor-associated macrophages, cancer-associated fibroblasts, tumor microenvironment, immunosuppression, monocyte reprogramming, ligand-receptor interactions, therapeutic target, chemoresistance, immunotherapy resistance, metastasis, solid tumors
MeSH terms
Cancer-Associated Fibroblasts, Tumor-Associated Macrophages, Animals, Cell Communication, Humans, Neoplasms, Signal Transduction, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: At the Interface of Tumor-Associated Macrophages and Fibroblasts: Immune-Suppressive Networks and Emerging Exploitable Targets. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-24-1690
The paper
Timperi, E., Croizer, H., Khantakova, D., Rana, M., Molgora, M., Guerriero, J. L., Mechta-Grigoriou, F., & Romano, E. (2024). At the Interface of Tumor-Associated Macrophages and Fibroblasts: Immune-Suppressive Networks and Emerging Exploitable Targets. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-24-1690

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.